Drug intelligence / Profile preview

Shengxian Quyu Huazhuo granules

Development stage: Unknown
Lead developer: First Affiliated Hospital of Henan University of Chinese Medicine
Administration: Oral

Overview

Shengxian Quyu Huazhuo granules is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Henan University of Traditional Chinese Medicine for the treatment of coronary heart disease (CHD). The name reflects its therapeutic principles: "Shengxian" refers to regulating the lifting and sinking of qi, while "Quyu Huazhuo" refers to removing blood stasis and resolving phlegm turbidity. It is intended for patients exhibiting TCM syndromes of qi deficiency and phlegm stasis. The drug is currently being evaluated in clinical trials as an add-on to standard Western medical therapy to assess its impact on cardiopulmonary exercise capacity, angina symptoms, and the incidence of major adverse cardiovascular events (MACE).

Other names: Shengxian Quyu Huazhuo

Targets

IL-6 (Interleukin 6)VEGFA (Vascular endothelial growth factor A)TP53 (Cellular Tumor Antigen p53 R175H)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Shengxian Quyu Huazhuo granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shengxian Quyu Huazhuo granules.

Explore the full profile